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ABSTRACT 
A prominent relationship has been proposed between compliance and various factors, like 
the patient's individual characteristics, the illness and medication being prescribed to the patient. 
We compared 20 manic patients who were non compliant to medication with a control group, who 
were matched on the demographic variable, illness variables and the treatment prescribed. We first 
examined the reason for non compliance from the patient's perspective, and found out the commonest 
reason for non compliance to be 'side effect of the medicines' (35.0%), followed by the sense of 
'feeling well' (30.0%). On assessing the patient's personality traits using 16PF, we found significant 
elevation on factor L, signifying characteristics like pretension, jealousy, suspiciousness etc. On the 
DMI, the patients got significantly lower scores on the variable PRN - indicating less use of defenses 
like inteilectualization and rationalization. Based on these findings we came to the conclusion that 
noncompiiant patients use less of mature defenses and more of primitive defenses. 
Key words - compliance, mania, personality traits, defense mechanisms. 
Non-compliance is a common problem 
encountered by all health professionals 
(Blackwell, 1992). Various factors which 
determine the compliance of a patient have been 
identified. These factors can be broadly classified 
into the following-patient variables (i.e. 
demographics, personality differences, attitude, 
and the defenses used, etc), illness variables 
(i.e. diagnosis, illness content, chronic illness, 
etc.), and treatment variables (i.e. treatment 
setting, simple or complicated treatment 
regimen, cost of the medicines, side effects of 
the medicines, etc.) (Blackwell, 1989, 1992, 
Fawcett, 1995). So far more than 200 variables 
have been examined, but more than half of the 
studies have failed to reveal any association 
between compliance and most of these variables 
(Blackwell, 1992). 
Non compliance has various serious 
consequences, like patients not receiving the Ml 
benefit of a treatment protocol to repeated and 
prolonged hospitalizations, hence the issue 
merits serious consideration by practicing 
clinicians. 
MATERIAL AND METHOD 
This study was conducted at the Central 
Institute of Psychiatry, Ranchi. The experimental 
group was taken from the OPD and constituted 
of 20 consecutive, non compliant manic patients, 
who fulfilled the ICD-10 criteria (WHO,1992) for 
Bipolar affective disorder, mania. Non 
compliance was defined as being off medication 
for atleast 1 month against medical advice. A 
control group of compliant manic patients who 
were matched for the demographic variables, 
(age of onset, duration of illness, number of 
illness episodes) and the treatment prescribed 
was also taken from the O.P.D. Only literate 
patients were included in the study. 
The exclusion criteria was : patients with any 
evidence of organicity, with any psychiatric 
comorbidity and aged below 16 years. 
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The details of the patient's demographic 
data, illness variables and medication were 
recorded. The personality was assessed using 
the Hindi version of the 16 Personality Factor 
Questionnaire (16 PF) (Kapoor, 1970 a & b; 
Kapoor & Tripathi, 1981 a & b) and the Defense 
Mechanisms Inventory (DMI) (Mrinal & Singhal, 
1984) was used to study the defense mechanism 
used by the patients. The reason for non 
compliance, as reported by the patient was also 
recorded. The sample constituted of employed 
and unemployed patients coming from rural as 
well as urban areas. Various level of education 
as well as socioeconomic status were adequately 
represented in the sample. 
RESULTS 
The experimental group consisted of 18 
males and 2 females. 13 patients were married 
and 7 patients were single. The mean age of the 
non compliant patients was 28.45 ±11.09yrs. 
whereas the mean age of the control group was 
26.45 ± 8.34 yrs (p=N.S). 
The mean age of illness onset of the 
experimental group was 21.05 ± 5.46 yrs. with the 
mean duration of illness being 5.75 ± 8.09 yrs. The 
mean number of episodes was 3.15 ±2.21. 
In the experimental group 10 patients were 
on mood stabilizers, 5 patients on mood 
stabilizers and antipsychoties and 5 patients only 
on antipsychoties. 
The commonest reasons cited for 
discontinuation of medication were side effects 
of the drugs (35.0%) and a sense of feeling well' 
(30.0%). This was followed by poor financial 
condition (10.0%), inability to contact the doctor 
(10.0%), social stigma (10.0%) and 
miscellaneous reasons (5.0%). 
On 16 PF, the non compliant patients had 
a significantly higher score on factor L compared 
to the compliant patients (6.20 ± 1.79 vs 4.35 ± 
2.25) (t=2.87, p<0.05). 
On DMI the non compliant patients had a 
significantly lower score on the variable 
principalization (PRN) (42.700 ± 5.312 vs 
46.3000 ± 4.943). 
DISCUSSION 
Our patients were matched on the 
demographic variables, illness variables and 
treatment variables as closely as was possible, 
and then we tried to examine the overt reasons 
for drug non-compliance (i.e. what the patients 
told us) and the covert reason (i.e. what the 
personality test and the defence mechanism 
inventory revealed to us). The commonest 
reason cited by the patients for discontinuing 
medication was side effects of drugs, a fact 
recognized by many. It is estimated that 20% to 
30% of bipolar patients discontinue lithium 
against medical advice because of side effects. 
In case of neuroleptics, the extremely distressing 
and frightening experience of dystonia, akathisia 
and akinesia have been shown to be directly 
associated with medication non compliance. 
Asymptomatic illness has been recognized as 
one of the factors that decreases compliance. 
Various workers have reported that in patients 
whose illness is in remission, the discontinuation 
of medication may reflect an attempt to deny 
the existence of the illness. 
The non compliant patients were found 
to have a higher score on factor L, which is 
indicative of characteristics like pretension, 
jealousy, suspiciousness of interference, 
irritability, etc. Much of the behaviour of such 
individuals may be identified with the persistent 
adoption of true projection. Our findings were 
consistent with the views of Book (1973), that 
patients with paranoid trends who rely on 
projective mechanisms and degree of fluidity in 
self-object differentiation, often experience the 
ingestion of medicine as a risk for being 
poisoned, influenced or hypnotized. A similar 
view was expressed by Fawcett (1995), that in 
patients who are extremely suspicious or who 
show high sensitivity to physical symptoms, any 
association with negative schema (i.e. fear of 
symptoms as evidence of damage to one's body 
and impending danger) often creates a negative 
attitude towards thje drug. 
The non compliant patients had a lower 
mean score on the factor-principalization, which 
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includes defenses that deal with conflicts through 
evoking a general pnnciple that 'Splits-off affect 
from the content and represses the former, like 
intellectualization and rationalization. These 
findings indicates that non-compliant patients use 
less of mature and sophisticated defenses and 
more of primitive defenses like projection, denial, 
identifications and displacement, in bipolar 
patients, denial has been shown to cause refusal 
to take lithium. In an earlier study, Gleser& Ihilevich 
(1969) had shown that the factor principalization 
is negatively correlated to the paranoia scale of 
the MMPI, which was similar to our findings. This 
further lends support to our views. 
In the end we would like to emphasize 
that there is nothing like a stereotypical 'drug 
defaulter' and that every patient we see is a 
potential defaulter. Compliance depends on a 
complex interaction between the patient, his 
illness, the physician and the medications he 
prescribes. Some of the risk factors are easy to 
control (such as the drug regimen and side 
effects of drugs), others are manageable, but 
more resistant to change (such as the patients 
personality and attitudes), and some are beyond 
our control (such as the patients age, sex, race 
etc). Our sample size was very small and had 
an over representation of males, hence any 
generalization should be made with caution. 
Further, issues like social support, family 
structure, perceived stress and therapist variable 
were not addressed to in this study. 
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